An analysis of 127 women with metastatic breast cancer was carried out. All patients were treated with aminoglutethimide: of 117 evaluable patients, 29 responded, 46 remained stable and 42 progressed. A series of patients' characteristics were analyzed for their prognostic importance for response to this drug. The most important features able to predict response were found to be a previous response to tamoxifen and a long disease-free survival after mastectomy.

Metastatic breast cancer: an analysis of prognostic factors in patients treated with aminoglutethimide / L., Repetto; P., Pronzato; A., Ardizzoni; G., Bertelli; M., Gulisano; D., Amoroso; G., Gardin; V., Fusco; A., Falcone; Conte, Pierfranco. - In: CHEMIOTERAPIA. - ISSN 0392-906X. - STAMPA. - 6:(1987), pp. 66-72.

Metastatic breast cancer: an analysis of prognostic factors in patients treated with aminoglutethimide.

CONTE, Pierfranco
1987

Abstract

An analysis of 127 women with metastatic breast cancer was carried out. All patients were treated with aminoglutethimide: of 117 evaluable patients, 29 responded, 46 remained stable and 42 progressed. A series of patients' characteristics were analyzed for their prognostic importance for response to this drug. The most important features able to predict response were found to be a previous response to tamoxifen and a long disease-free survival after mastectomy.
1987
6
66
72
Metastatic breast cancer: an analysis of prognostic factors in patients treated with aminoglutethimide / L., Repetto; P., Pronzato; A., Ardizzoni; G., Bertelli; M., Gulisano; D., Amoroso; G., Gardin; V., Fusco; A., Falcone; Conte, Pierfranco. - In: CHEMIOTERAPIA. - ISSN 0392-906X. - STAMPA. - 6:(1987), pp. 66-72.
L., Repetto; P., Pronzato; A., Ardizzoni; G., Bertelli; M., Gulisano; D., Amoroso; G., Gardin; V., Fusco; A., Falcone; Conte, Pierfranco
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/738344
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact